← Leaderboards
Eric M Ostertag
Transposagen Biopharmaceuticals, Inc.
$4,471,162
Attributed
$4,471,162
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$4,471,162 · 7
By mechanism
R44$3,226,140 · 2
R43$1,245,022 · 5
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyCommunitiesProductionMutagenesisAnimal ModelHuman DiseaseKnock-OutRattusCellsGenerationsGenesMutationSuccessAnimalsGerm LinesResourcesEmbryonic Stem CellSperm CellExhibitsPhysiologyRat GenomeGenetic ManipulationMutantEvent
Grant awards (12)
Novel reporter cell lines for neurotoxicant assays$225,000
R43 · FY2014 · ES · contact PI
Creation of hyperactive transposons for mutagenesis in rodents$899,865
R44 · FY2011 · RR · contact PI
Novel method to create knockout rats using endonucleases and spermatagonialstem$342,046
R43 · FY2011 · GM · contact PI
Generation of Site-Specific Recombinase-Expressing Transgenic Rats using an Enhan$60,456
R43 · FY2011 · HG · contact PI
Generation of Site-Specific Recombinase-Expressing Transgenic Rats using an Enhan$42,001
R43 · FY2011 · HG · contact PI
Creation of hyperactive transposons for mutagenesis in rodents$779,947
R44 · FY2010 · RR · contact PI
Generation of Site-Specific Recombinase-Expressing Transgenic Rats using an Enhan$180,181
R43 · FY2010 · HG · contact PI
Creation of hyperactive transposons for mutagenesis in rodents$295,614
R43 · FY2009 · RR · contact PI
L1 retrotransposon-based mutagenesis for rat models of human diseases$189,865
R44 · FY2009 · RR · contact PI
L1 retrotransposon-based mutagenesis for rat models of human diseases$668,320
R44 · FY2008 · RR · contact PI
L1 retrotransposon-based mutagenesis for rat models of human diseases$688,143
R44 · FY2007 · RR · contact PI
L1 mutagenesis for mammalian models of human diseases$99,724
R43 · FY2005 · RR